000275592 001__ 275592
000275592 005__ 20240411140924.0
000275592 0247_ $$2doi$$a10.22354/24223794.1092
000275592 0247_ $$2ISSN$$a0123-9392
000275592 0247_ $$2ISSN$$a2422-3794
000275592 037__ $$aDKFZ-2023-00803
000275592 082__ $$a610
000275592 1001_ $$aErira, Alveiro$$b0
000275592 245__ $$aCaracterización transcriptómica de bacterias relacionadas con eubiosis y disbiosis en pacientes con y sin carcinoma escamocelular oral
000275592 260__ $$aMedellín, Colombia$$bACIN$$c2022
000275592 3367_ $$2DRIVER$$aarticle
000275592 3367_ $$2DataCite$$aOutput Types/Journal article
000275592 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1682323615_14650
000275592 3367_ $$2BibTeX$$aARTICLE
000275592 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000275592 3367_ $$00$$2EndNote$$aJournal Article
000275592 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000275592 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000275592 7001_ $$aGamboa, Fredy$$b1
000275592 7001_ $$0P:(DE-He78)a30064f6b2d9ab959d35315d7668c091$$aCid-Arregui, Ángel$$b2$$udkfz
000275592 7001_ $$aTobar-Tosse, Fabian$$b3
000275592 7001_ $$aGarcía, Dabeiba A.$$b4
000275592 773__ $$0PERI:(DE-600)2090560-9$$a10.22354/24223794.1092$$n4$$p425 - 434$$tInfectio$$v26$$x0123-9392$$y2022
000275592 909CO $$ooai:inrepo02.dkfz.de:275592$$pVDB
000275592 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-03
000275592 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-03
000275592 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-09-03
000275592 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-09-03
000275592 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Double blind peer review$$d2020-09-03
000275592 915__ $$0LIC:(DE-HGF)CCBYNCNDNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)$$bDOAJ$$d2020-09-03
000275592 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-03
000275592 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-03
000275592 9141_ $$y2022
000275592 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a30064f6b2d9ab959d35315d7668c091$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000275592 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000275592 9201_ $$0I:(DE-He78)D122-20160331$$kD122$$lD122 AG Gezielte Tumorvakzine$$x0
000275592 980__ $$ajournal
000275592 980__ $$aVDB
000275592 980__ $$aI:(DE-He78)D122-20160331
000275592 980__ $$aUNRESTRICTED